REIT REITs mREITs image Log on |  Join ($$) Mortgage Real Estate Investment Trusts image Welcome, guest! Learn about guest access          
reits.valueforum.com
CENCORA INC (NYSE: COR)
Last Trade
1:04 p.m. - 216.875
Change
 0.665 ( 0.31%)
Shares Traded
11,656
Day's Volume
445,631
Book Value
NA
Price/Book
NA
Beta
0.6951
Day's Range
214.7686 - 216.98
Prev Close
216.21
Open
215.83
52 Wk Range
163.91 - 246.75
EPS
8.53
PE
23.73
Quarterly Div/Shr
0.51
Ex-Div
05/09/24
Yield
0.94%
Shares Out.
199.45M
Market Cap.
43.26B
  • 1 Year Stock Performance:

CAGR - Chart the growth of a $10K investment in COR

   Click here to search the Discussion Forum section for posts mentioning stock symbol COR »

Related news from
Fri, 24 May 2024
18:00:24 +0000
After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February
U.S. drug wholesaler Cencora Inc (NYSE:COR), formerly AmerisourceBergen, is notifying affected individuals about their personal and highly sensitive medical information stolen during a cyberattack earlier this year. The healthcare giant revealed that the breached data includes patient names, postal addresses, dates of birth, health diagnoses, and medication details. In letters this week, TechCrunch reported that Cencora had obtained patients’ data through partnerships with other drug makers as p
Wed, 22 May 2024
21:44:00 +0000
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance and Raises Fiscal 2024 Guidance
CONSHOHOCKEN, Pa., May 22, 2024--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $400 million in a private transaction.
Sat, 04 May 2024
12:34:19 +0000
There's A Lot To Like About Cencora's (NYSE:COR) Upcoming US$0.51 Dividend
Readers hoping to buy Cencora, Inc. ( NYSE:COR ) for its dividend will need to make their move shortly, as the stock is...
Thu, 02 May 2024
13:40:11 +0000
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Thu, 02 May 2024
12:03:37 +0000
Cencora Second Quarter 2024 Earnings: Misses Expectations
Cencora ( NYSE:COR ) Second Quarter 2024 Results Key Financial Results Revenue: US$68.4b (up 7.8% from 2Q 2023). Net...
Wed, 01 May 2024
10:30:00 +0000
Cencora Reports Fiscal 2024 Second Quarter Results
CONSHOHOCKEN, Pa., May 01, 2024--Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 second quarter ended March 31, 2024, revenue increased 7.8 percent year-over-year to $68.4 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $2.09 for the second quarter of fiscal 2024 compared to $2.13 in the prior year second quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described belo
Mon, 15 Apr 2024
13:40:11 +0000
Is Artivion (AORT) Outperforming Other Medical Stocks This Year?
Here is how Artivion (AORT) and Cencora (COR) have performed compared to their sector so far this year.
Mon, 15 Apr 2024
13:40:11 +0000
Here's Why Cencora (COR) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Fri, 05 Apr 2024
12:30:00 +0000
Cencora Announces Date and Time for Second Quarter Fiscal 2024 Earnings Release
CONSHOHOCKEN, Pa., April 05, 2024--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2024 on Wednesday, May 1, 2024, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 1, 2024.
Thu, 28 Mar 2024
13:40:12 +0000
Are Medical Stocks Lagging Artivion (AORT) This Year?
Here is how Artivion (AORT) and Cencora (COR) have performed compared to their sector so far this year.
Wed, 27 Mar 2024
13:45:11 +0000
Why Cencora (COR) is a Top Growth Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Tue, 12 Mar 2024
12:30:00 +0000
Cencora Announces Leadership Succession Plan
CONSHOHOCKEN, Pa., March 12, 2024--Cencora, Inc. (NYSE: COR) today announced that Steven H. Collis will retire as President and Chief Executive Officer of the Company and transition to the role of Executive Chair of the Cencora Board of Directors, effective October 1, 2024. Robert P. Mauch, PharmD, PhD, current Chief Operating Officer of Cencora, will succeed Collis as President and CEO, and will also be appointed as a member of the Company's Board, effective the same date.
Fri, 23 Feb 2024
14:45:11 +0000
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Thu, 08 Feb 2024
00:33:19 +0000
Walgreens Boots pockets $992 million after cutting Cencora stake for third time
The proceeds include around $942 million from shares sold as well as about $50 million from a concurrent share repurchase by Cencora, formerly AmerisourceBergen. Walgreens has been grappling with waning demand for COVID-19 vaccines and testing as well as decreased spending on personal care and beauty products by inflation-weary consumers. It said it now owns around 13% of Cencora's common stock from 15% previously, and that it would use the sale proceeds primarily to pay down debt.
Wed, 07 Feb 2024
23:26:00 +0000
Cencora Announces Common Share Repurchase From Walgreens Boots Alliance
CONSHOHOCKEN, Pa., February 07, 2024--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance’s sale of Cencora shares pursuant to Rule 144 under the Securities Act of 1933, as amended.
Wed, 07 Feb 2024
23:16:00 +0000
Walgreens Boots Alliance Sells Shares of Cencora For $992 Million of Proceeds
DEERFIELD, Ill., February 07, 2024--Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that it has sold shares of Cencora, Inc. (NYSE: COR) common stock pursuant to Rule 144 for proceeds of approximately $942 million and, subject to the completion of the Rule 144 sale, a concurrent share repurchase by Cencora in the amount of approximately $50 million.
Wed, 07 Feb 2024
18:11:00 +0000
Cencora Closes $500 Million Senior Notes Offering
CONSHOHOCKEN, Pa., February 07, 2024--Cencora, Inc. (NYSE: COR) today announced the closing of its public offering of $500 million aggregate principal amount of its 5.125% Senior Notes due 2034 (the "Notes"), in an underwritten registered public offering. The offering was made pursuant to an effective shelf registration statement Cencora filed with the Securities and Exchange Commission (the "SEC") on November 23, 2021.
Mon, 05 Feb 2024
23:18:00 +0000
Cencora Prices $500 Million 5.125% Senior Notes Due 2034
CONSHOHOCKEN, Pa., February 05, 2024--Cencora, Inc. (NYSE: COR) today announced that it priced $500 million aggregate principal amount of its 5.125% Senior Notes due 2034 (the "Notes"), in an underwritten registered public offering. The offering is being made pursuant to an effective shelf registration statement Cencora filed with the Securities and Exchange Commission (the "SEC") on November 23, 2021. The offering is expected to close on February 7, 2024, subject to the satisfaction of customar
Sun, 04 Feb 2024
12:50:07 +0000
Companies test out different ways to talk about ESG without saying 'ESG'
Mentions of ESG are falling again during this earnings season as bosses come up with different ways of talking about social responsibility and climate change.
Wed, 31 Jan 2024
11:30:00 +0000
Cencora Reports Fiscal 2024 First Quarter Results
CONSHOHOCKEN, Pa., January 31, 2024--Cencora, Inc. (NYSE: COR) today reported that in its fiscal year 2024 first quarter ended December 31, 2023, revenue increased 15.0 percent year-over-year to $72.3 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $2.98 for the first quarter of fiscal 2024 compared to $2.33 in the prior year first quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes items described

If you are already a Value Forum member but are not logged on, click here to log on. If you are a guest, thank you for visiting ValueForum -- click here for information about guest access or click here to join -- a Trial Pass can be purchased for $6.99 to help you decide if you want to commit to longer term membership. Did you know there are customized portals into VF like REITs.ValueForum.com and also My ValueForum which lets you customize your VF experience to the posters and topics that most interest you!


"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "I joined almost three years ago and have never been sorry. The search features here are terrific." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2024, Powered in part by Ticker TechnologiesContact Us

Cencora Inc (COR)